Ceredase alglucerase enzyme data

Low doses of the Cambridge, Mass., company's enzyme were tested in 25 patients by independent investigators at the Academic Medical Centre in Amsterdam, who concluded that frequent use of low doses would obtain the best outcome for the lowest cost.

As reported in the Lancet, doses as low as 15 U/kg per month, given in divided doses three times weekly, were able to improve disease symptoms. ...